Approval and publication of listing prospectus of Observe Medical ASA

Navamedic ASA, 1 November 2019: Reference is made to Navamedic ASA’s (“NAVA”) and Observe Medical ASA’s (“Observe Medical”) stock exchange announcements dated 30 October 2019 and 31 October 2019, regarding Oslo Børs’ approval of Observe Medical’s application for listing of its shares on Oslo Axess (the “Listing”) and the completion of the demerger of NAVA, respectively.

The prospectus for the Listing (the “Prospectus”) was approved by the Financial Supervisory Authority of Norway today, on 1 November 2019. The Prospectus has been published today and is available at www.observemedical.com.

Observe Medical’s shares will be listed on Oslo Axess on Monday 4 November 2019. Hard copies of the Prospectus may be obtained by contacting Observe Medical.

Share this post

Share on facebook
Share on twitter
Share on linkedin
Share on email